Search
Eikon Therapeutics Ord Shs
EIKNAdd to Watchlist
12.540USD
+0.290+2.37%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
663.20MMarket Cap
LossP/E TTM
More Details of Eikon Therapeutics Ord Shs Company
Eikon Therapeutics Ord Shs Info
Ticker SymbolEIKN
Company nameEikon Therapeutics Inc
IPO dateFeb 05, 2026
CEOPerlmutter (Roger M)
Number of employees384
Security typeOrdinary Share
Fiscal year-endFeb 05
Address230 Harriet Tubman Way
CityMILLBRAE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94030
Phone13026587581
Websitehttps://eikontx.com/
Ticker SymbolEIKN
IPO dateFeb 05, 2026
CEOPerlmutter (Roger M)
Company Executives of Eikon Therapeutics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
Dr. Leon Chen, Ph.D.
Dr. Leon Chen, Ph.D.
Director
Director
--
--
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
FAQs
Who are the top five shareholders of Eikon Therapeutics Ord Shs?
The top five shareholders of Eikon Therapeutics Ord Shs are: Dr. Roger M. Perlmutter, M.D., Ph.D.